SA Tuberculosis Vaccine Initiative

Search

January 2021

8 January 2020 Opinion Piece: Why I choose COVID-19 vaccination based on verifiable evidence - 8 Jan 2021 - 14:15
4 January 2020 News: SATVI researcher awarded full IDM membership - 6 Jan 2021 - 09:00

December 2020

9 December 2020 ID93+GLA-SE candidate TB vaccine appears safe and immunogenic in treated TB patients - 9 Dec 2020 - 20:30
3 December 2020 Vacancy SATVI Project Manager - 3 Dec 2020 - 13:30

November 2020

19 November 2020 Research Postnatal expansion, maturation and functionality of MR1T cells in humans - 19 Nov 2020 - 19:45

October 2020

9 October 2020 Research: Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines - 10 Oct 2020 - 19:30

September 2020

September Research: S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis - 9 Sep 2020 - 15:30
September Research Fetal public Vγ9Vδ2 T cells expand and gain potent cytotoxic functions early after birth - 9 Sep 2020 - 14:00

August 2020

4 August 2020 Research Vacancy: Postdoc Fellow - 4 Aug 2020 - 08:45
4 August 2020 Research Vacancy: Postdoc Fellow - 4 Aug 2020 - 08:45

July 2020

24 July 2020 Research Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB - 24 Jul 2020 - 14:15
24 July 2020 Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB - 24 Jul 2020 - 14:15
23 July 2020 Research Immune serum-activated human macrophages coordinate with eosinophils to immobilize Ascaris suum larvae - 23 Jul 2020 - 08:45
5 July 2020 Research published: Regional changes in TB disease burden among adolescents in South Africa - 9 Jul 2020 - 12:15

May 2020

25 May 2020 New multi-functional TB blood test validated - 25 May 2020 - 10:30
8 May 2020 Research A new algorithm to study millions of receptors that T cells use to recognise pathogens - 8 May 2020 - 17:30

April 2020

22 April 2010 SATVI Annual Report 2019 available - 23 Apr 2020 - 13:30
20 April 2020 Latest Research: Renewing the fight against TB with an old vaccine - 23 Apr 2020 - 12:45
7 April 2020 Research: Immune Phenotype and Functionality of Mtb-Specific T-Cells in HIV/TB Co-Infected Patients on Antiretroviral Treatment. - 16 Apr 2020 - 10:00

March 2020

15 March 2020 Research Blood transcriptional signatures for tuberculosis testing - 21 Mar 2020 - 20:30
4 March 2020 Best paper award for UCT TB vaccine research - 7 Mar 2020 - 09:00
2 March 2020 - Clinical Development of New TB Vaccines: Recent Advances and Next Steps. - 5 Mar 2020 - 22:30

February 2020

22 February 2020 Research: Immune correlates of tuberculosis disease and risk translate across species. - 23 Feb 2020 - 11:30

January 2020

21 January 2020 Research: Headway made towards biosignatures for tuberculosis incipient - 21 Jan 2020 - 15:00

December 2019

2 December 2019: EDCTP funded clinical trial testing new tuberculosis vaccine initiates vaccinations - 18 Dec 2019 - 08:45

November 2019

22 November 2019 Research Preferred product characteristics for therapeutive vaccines - 22 Nov 2019 - 13:45
14 November 2019 Research: Book Chapter: Diagnosing childhood tuberculosis during a vaccine trial in South Africa. - 14 Nov 2019 - 22:45
SATVI researcher Dr Luabeya awarded ‘C’ rating from the South African National Research Foundation. - 13 Nov 2019 - 15:45
4 November 2019 SATVI Senior Research officer Elisa Nemes promoted to Associate Professor - 4 Nov 2019 - 15:30
4 November 2019 SATVI Senior Research officer promoted to Associate Professor - 4 Nov 2019 - 15:30
4 November 2019 SATVI Senior Research officer promoted to Associate Professor - 4 Nov 2019 - 15:30
4 November 2019 SATVI Senior Research officer promoted to Associate Professor - 4 Nov 2019 - 15:30
4 November 2019 SATVI Senior Research officer promoted to Associate Professor - 4 Nov 2019 - 15:30

October 2019

30 October 2019 Press Conference:Final results M72/AS01E candidate vaccine - 30 Oct 2019 - 19:30
30 October 2019 Press Conference 30 October 2019 Press Conference: Final results M72/AS01E candidate vaccine - 30 Oct 2019 - 13:45
TB Science Conference, 2019: Final results from M72/AS01E candidate vaccine announced - 29 Oct 2019 - 17:00
23 October 2019 Vacancy: Laboratory Technologist - 24 Oct 2019 - 11:45

September 2019

September 2019 Latest research: Plasma Type I IFN Protein Concentrations in Human Tuberculosis - 13 Sep 2019 - 23:00
September 2019 Latest Research Non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis. - 13 Sep 2019 - 22:45
Latest Research: FDG-PET/CT as a non-invasive biomarker for R assessing adequacy of treatment and predicting relapse patients treated for Pulmonary Tuberculosis - 2 Sep 2019 - 15:45

Pages

Contact us

General Enquiries:

Tel +27 21 406 6791

Worcester Field Site Office

Tel+ 27 23 346 5400

Email: Information

Cape Town Offices:

Wernher and Beit South Building, Room S2.01, University of Cape Town , Anzio Road, OBSERVATORY, 7925

Tel: +27 21 406 6791

Fax:+27 21 406 6081

Email: Director

Worcester Site Office:

SATVI Project Office, University of Cape Town, Brewelskloof Hospital,  Haarlem Street, WORCESTER, 6850.

Tel: +27 23 346 5400

Fax: +27 23 346  5406

Email: Field Site Manager

Google maps:  Click here GPS: -33.620455, 19.458576

Map to Worcester Field Office